SCHEMBL3979295

SCHEMBL3979295

Cc1c(-c2ccccc2)ccc(C(N)=O)c1OCCCl

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCAT2 O15382 1/20 0.43
PSMD14 O00487 1/20 0.39
MMP2 P08253 1/20 0.39
BLM P54132 1/20 0.39
IKBKB O14920 1/20 0.38
KDM4E B2RXH2 5/20 0.38
BRD4 O60885 1/20 0.37
ALDH1A1 P00352 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
LMNA P02545 4/20 0.36
MAPK1 P28482 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
HTT P42858 2/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
NR1I2 O75469 1/20 0.35
CHRM2 P08172 1/20 0.35
CYP3A4 P08684 1/20 0.35
ADRA2A P08913 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3974955 0.87 BCAT2 (0.43) BCAT2PSMD14MMP2BLMIKBKB
SCHEMBL3981622 0.85 BCAT2 (0.44) BCAT2IKBKBKDM4EALDH1A1SMN1; SMN2
SCHEMBL3973836 0.82 BCAT2 (0.54) BCAT2IKBKBKDM4EALDH1A1SMN1; SMN2
SCHEMBL18641956 0.80 IKBKB (0.52) BCAT2IKBKBKDM4EBRD4HTT
SCHEMBL18816707 0.76 BCAT2 (0.45) BCAT2IKBKBKDM4EBRD4MEN1
SCHEMBL3898825 0.75 BCAT2 (0.58) BCAT2IKBKBKDM4EBRD4ALDH1A1
SCHEMBL17829925 0.74 BCAT2 (0.56) BCAT2IKBKBKDM4EBRD4ALDH1A1
SCHEMBL3975447 0.72 BCAT2 (0.44) BCAT2IKBKBKDM4EBRD4SMN1; SMN2
SCHEMBL3973587 0.71 MKNK1 (0.48) KDM4EALDH1A1SMN1; SMN2LMNAMAPK1
SCHEMBL18816701 0.71 BCAT2 (0.53) BCAT2IKBKBKDM4EBRD4LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2054383-A2 NOVEL COMPOUNDS AS ANTAGONISTS OR INVERSE AGONISTS AT OPIOID RECEPTORS SmithKline Beecham Corporation (US) 2009-05-06 EP disclosed
WO-2008021849-A2 NOVEL COMPOUNDS AS ANTAGONISTS OR INVERSE AGONISTS AT OPIOID RECEPTORS SMITHKLINE BEECHAM CORPORATION (US) 2008-02-21 WO disclosed